Brachytherapy

What is it?

Brachytherapy delivers radiation internally. There are 2 main types: low-dose seed implant brachytherapy and high-dose rate brachytherapy (HDR).

Low-dose seed implant brachytherapy
  • Usually recommended to men with lowergrade cancers that are contained within the prostate gland.
  • Between 80 and 100 radioactive seeds, the size of a grain of rice, are implanted directly into the prostate.
  • Each seed releases low-energy level radiation steadily over several months.
HDR
  • Reserved for patients with high-grade cancers.
  • High-dose radiation is received through approximately 15 needles in the prostate, concentrating on the cancerous areas.
What is done?

Low-dose seed implant brachytherapy
  • The seeds are inserted through the skin in the perineum.
  • Procedure is performed under either general or spinal anesthesia and lasts approximately 1 hour.
HDR
  • Under anesthesia, approximately 10–15 needles are inserted through the perineum.
  • These needles are wired to the radiation source that delivers a high radiation dose to the prostate.
  • The needles are then removed.
  • The treatment takes 10–20 minutes.
What to expect?

Low-dose seed implant brachytherapy
  • A catheter may be used for a short time for urine drainage.
HDR
  • Often preceded or followed by a few weeks of external beam radiation.
  • Sometimes HDR treatments are given over a few days and the external beam radiation is not needed.
Side effects and risks
  • Side-effects of brachytherapy are similar to those of external beam radiation.
  • Brachytherapy differs slightly in the following ways:
    • Dominant short-term side-effect is irritation to the bladder and urethra
    • Acute urinary r etention may develop
    • Bowel irritation is relatively uncommon
    • Side effects may last months
Long term side effects
  • Very rare risk of incontinence of urine or chronic urinary obstruction (both less than 5%).
  • Erectile Dysfunction may occur, though many men will be able to achieve an erection with the use of prescription medication.

For more information and support:


Prostate Cancer Awareness Month

Donate Now!


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive